background image

Paid Clinical Trials Utah

Discover 1,168 paid clinical trials in Utah. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Salt Lake City, Redwood City, Seattle, Dallasshow 7 more

Code:

NCT04064827

Conditions

Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism (SHPT)

Eligibility Criteria

Sex: All

Age: 0 - 9

Healthy Volunteers: Not accepted

Interventions

Paricalcitol

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Recruiting
PHASE2

Sponsor:

Gilead Sciences

Location:

Salt Lake City, Littleton, Albuquerque, Los Angelesshow 31 more

Code:

NCT03547973

Conditions

Metastatic Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Govitecan-hziy

Pembrolizumab

Cisplatin

Avelumab

Zimberelimab

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting
PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

West Jordan, Colorado Springs, Lincoln, Los Angelesshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
PHASE3

Sponsor:

Melt Pharmaceuticals

Location:

Pleasant Grove, Grand Junction, Chico, Sioux Fallsshow 8 more

Code:

NCT06383273

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MELT-300 sublingual tablet

Midalozam sublingual tablet

Placebo sublingual tablet

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

Recruiting

Sponsor:

Dennis M. McNamara, MD, MS

Location:

Murray, Aurora, Los Angeles, Orangeshow 43 more

Code:

NCT05180773

Conditions

Peripartum Cardiomyopathy, Postpartum

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bromocriptine

Placebo

Guideline Directed Medical Therapy for Heart Failure (GDMT)

Rivaroxaban

Second Placebo

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Salt Lake City, Arvada, Denver, Surpriseshow 121 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting
PHASE3

Sponsor:

Sanofi

Location:

Salt Lake City, Las Vegas, Fort Collins, Aurorashow 78 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Recruiting
PHASE2

Sponsor:

Escient Pharmaceuticals, Inc

Location:

Murray, North Las Vegas, Boise, Scottsdaleshow 32 more

Code:

NCT06077773

Conditions

Chronic Spontaneous Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Oral EP262

Placebo

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Recruiting

Sponsor:

Carelon Research

Location:

Salt Lake City, Aurora, Phoenix, Los Angelesshow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Salt Lake City, Aurora, Phoenix, Sacramentoshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

Popular cities in Utah

Offering a robust healthcare network and esteemed research institutions, Utah is a significant hub for clinical trials. Leading centers like the University of Utah Health, Huntsman Cancer Institute, and the Intermountain Healthcare system are at the forefront of medical research and innovation. Utah's strong emphasis on research and its collaborative environment make it a prominent state for conducting impactful clinical trials.

Why choose Utah for clinical trials?

Common conditions studied in Utah

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Utah